These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8589014)

  • 1. Acute promyelocytic leukaemia with t(15;17) following treatment of Hodgkin's disease--a report of 4 cases.
    Gillis S; Sofer O; Zelig O; Dann EJ; Lotan H; Ben Yehuda D; Isacson R; Rachmilewitz EA; Ben-Bassat I; Polliack A
    Ann Oncol; 1995 Oct; 6(8):777-9. PubMed ID: 8589014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy-related acute promyelocytic leukemia with t(15;17) (q22;q12) following chemotherapy with drugs targeting DNA topoisomerase II. A report of two cases and a review of the literature.
    Hoffmann L; Möller P; Pedersen-Bjergaard J; Waage A; Pedersen M; Hirsch FR
    Ann Oncol; 1995 Oct; 6(8):781-8. PubMed ID: 8589015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unique case of t(15;17) acute promyelocytic leukaemia (M3) developing into acute myeloblastic leukaemia (M1) with t(7;21) at relapse.
    Jubashi T; Nagai K; Miyazaki Y; Nakamura H; Matsuo T; Kuriyama K; Tomonaga M
    Br J Haematol; 1993 Apr; 83(4):665-8. PubMed ID: 8518183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute promyelocytic leukaemia and Hodgkin's disease in the same patient.
    Flanagan NG; Whitson A; Patel KB; Ridway JC
    J Clin Pathol; 1994 Jun; 47(6):565-6. PubMed ID: 8063946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired acute myelogenous leukemia after therapy for acute promyelocytic leukemia with t(15;17): a case report and review of the literature.
    Betancourt-García RD; Castro J; Fernández AC; López-Enríquez A; Fradera J; Pacheco E
    P R Health Sci J; 2009 Jun; 28(2):146-50. PubMed ID: 19530558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript.
    Park TS; Choi JR; Yoon SH; Song J; Kim J; Kim SJ; Kwon O; Min YH
    Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of therapy-related extramedullary acute promyelocytic leukemia.
    Chen Z; Mostafavi HS; Shevrin DH; Morgan R; Vye MV; Stone JF; Sandberg AA
    Cancer Genet Cytogenet; 1996 Jan; 86(1):29-30. PubMed ID: 8616781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy-related acute myeloid leukemia and myelodysplasia after successful treatment of acute promyelocytic leukemia.
    Zompi S; Viguié F
    Leuk Lymphoma; 2002 Feb; 43(2):275-80. PubMed ID: 11999558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.
    Josting A; Wiedenmann S; Franklin J; May M; Sieber M; Wolf J; Engert A; Diehl V;
    J Clin Oncol; 2003 Sep; 21(18):3440-6. PubMed ID: 12668650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy-related acute myeloid leukaemia after successful therapy for acute promyelocytic leukaemia with t(15;17): a report of two cases and a review of the literature.
    Zompi S; Legrand O; Bouscary D; Blanc CM; Picard F; Casadevall N; Dreyfus F; Marie JP; Viguié F
    Br J Haematol; 2000 Sep; 110(3):610-3. PubMed ID: 10997972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV).
    Wheeler C; Khurshid A; Ibrahim J; Elias A; Mauch P; Ault K; Antin J
    Leuk Lymphoma; 2001 Feb; 40(5-6):499-509. PubMed ID: 11426523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High risk of therapy-related leukemia after BEAM chemotherapy and autologous stem cell transplantation for previously treated lymphomas is mainly related to primary chemotherapy and not to the BEAM-transplantation procedure.
    Pedersen-Bjergaard J; Pedersen M; Myhre J; Geisler C
    Leukemia; 1997 Oct; 11(10):1654-60. PubMed ID: 9324285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute promyelocytic leukemia with t(15;17) following inhibition of DNA topoisomerase II.
    Pedersen-Bjergaard J
    Ann Oncol; 1995 Oct; 6(8):751-3. PubMed ID: 8589010
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks.
    Smith MA; Rubinstein L; Ungerleider RS
    Med Pediatr Oncol; 1994; 23(2):86-98. PubMed ID: 8202047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy-related acute myelomonocytic leukemia following successful treatment for acute promyelocytic leukemia.
    Todisco E; Testi AM; Avvisati G; Moleti ML; Cedrone M; Cimino G; Mancini F; Amadori S; Mandelli F
    Leukemia; 1995 Sep; 9(9):1583-5. PubMed ID: 7658728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy-related acute promyelocytic leukemia: a report on 16 cases.
    Detourmignies L; Castaigne S; Stoppa AM; Harousseau JL; Sadoun A; Janvier M; Demory JL; Sanz M; Berger R; Bauters F
    J Clin Oncol; 1992 Sep; 10(9):1430-5. PubMed ID: 1517786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy-related acute promyelocytic leukemia following etoposide-based chemotherapy in non-seminomatous germ cell tumor.
    Kumar TN; ; Gandhi LV; Raghunadharao D; Sadashivudu G
    J Postgrad Med; 2014; 60(1):84-5. PubMed ID: 24625948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy-related acute promyelocytic leukemia.
    Beaumont M; Sanz M; Carli PM; Maloisel F; Thomas X; Detourmignies L; Guerci A; Gratecos N; Rayon C; San Miguel J; Odriozola J; Cahn JY; Huguet F; Vekhof A; Stamatoulas A; Dombret H; Capote F; Esteve J; Stoppa AM; Fenaux P
    J Clin Oncol; 2003 Jun; 21(11):2123-37. PubMed ID: 12775738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
    Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
    Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.